Pexip delivers strong growth and early market traction on new technology innovation
Oslo, Norway, May 6, 2021 - The video communications provider, Pexip, today presented its quarterly results for the first quarter of 2021.
Pexip AS
Q1 2021
Pexip s subscription base measured in Annual Recurring Revenue (ARR) reached USD 87.2 million in Q1 2021, up from USD 56.7 million in Q1 2020, representing an increase of 54%. The growth was driven by several key customer wins including: New South Wales Health in Australia (USD 2.4 million over three years), to help power virtual healthcare visits; the UK Foreign, Commonwealth & Development Office (more than USD 1 million over three years), to enable connectivity between their video conferencing equipment and Microsoft Teams; and Honeywell, the American Fortune 500 conglomerate (undisclosed contract value), to provide the company’s video rooms with features such as Microsoft Teams interoperability and One Touch Join functionality. At the sam
INVISIO receives order for SEK 40 million from existing US customer
STOCKHOLM, May 5, 2021 /PRNewswire/
INVISIO has received an order worth SEK 40 million from an existing customer in the US Department of Defense. The order is for advanced communication and hearing protection systems. Delivery will be within six months. We are proud that INVISIO will deliver the company s advanced communication system to units of the US Department of Defense. Our systems are world-leading in their field and this order further strengthens our position, says Lars Højgård Hansen, CEO of INVISIO.
The INVISIO system offers improved communication capacities in noisy environments at the same time as the solution protects the users hearing, which gives operational and tactical advantages, along with improved situational awareness.
(2)
Q1 2021 net sales rise 52% (48% CER) to $567.2 million, exceeds outlook for at least 45% CER growth; adj. EPS up 94% to $0.66 ($0.65 CER), exceeds outlook for ~$0.60-0.62 CER
16% CER growth to $364 million from non-COVID product groups, represent 64% of total sales, while COVID-19 product group sales rise 186% CER to $203 million
Q1 2021 operating cash flow rises over 700% to $128.6 million, free cash flow of $82.3 million
Reaffirming full-year 2021 outlook for ~18-20% CER net sales growth and ~$2.42-2.46 CER adjusted diluted EPS
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced strong results of operations for the first quarter of 2021, exceeding the goals for net sales and adjusted earnings per share.
202
1 – Millicom International Cellular S.A. (“Millicom”) announces that it has signed agreements for the sale of its operations in Tanzania and for its stake in the AirtelTigo joint venture in Ghana. Once closed, the transactions will complete Millicom’s multi-year plan to divest its African operations and focus on its Latin America markets.
In Tanzania, Millicom has agreed to sell its entire operations to a consortium led by Axian, a pan-African group that was part of the consortium that acquired Millicom’s operations in Senegal in 2018.
In Ghana, Millicom along with its joint venture partner, Bharti Airtel Limited, have signed a definitive agreement for the transfer of AirtelTigo to the Government of Ghana. Millicom will take a $25 million charge as a result of this agreement.
Share this article
Share this article
BOSTON, April 29, 2021 /PRNewswire/ Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that the full peer-reviewed results of the IMproving PlasmA CollecTion (IMPACT) trial have been published in TRANSFUSION, the prime journal for transfusion medicine related research. The publication expands upon the IMPACT trial data presented in October 2020 in a plenary session at the AABB conference. IMPACT, a multicenter, prospective and double-blinded study, is one of the largest randomized controlled trials of plasmapheresis. The trial involved 3,443 donors who underwent 23,137 plasma donations.